168 related articles for article (PubMed ID: 19801173)
21. Concise review: non-cell autonomous reprogramming: a nucleic acid-free approach to induction of pluripotency.
Parameswaran S; Balasubramanian S; Rao MS; Ahmad I
Stem Cells; 2011 Jul; 29(7):1013-20. PubMed ID: 21544901
[TBL] [Abstract][Full Text] [Related]
22. Multiple roles of p53-related pathways in somatic cell reprogramming and stem cell differentiation.
Yi L; Lu C; Hu W; Sun Y; Levine AJ
Cancer Res; 2012 Nov; 72(21):5635-45. PubMed ID: 22964580
[TBL] [Abstract][Full Text] [Related]
23. Linking the p53 tumour suppressor pathway to somatic cell reprogramming.
Kawamura T; Suzuki J; Wang YV; Menendez S; Morera LB; Raya A; Wahl GM; Izpisúa Belmonte JC
Nature; 2009 Aug; 460(7259):1140-4. PubMed ID: 19668186
[TBL] [Abstract][Full Text] [Related]
24. Combined RNA-seq and RAT-seq mapping of long noncoding RNAs in pluripotent reprogramming.
Du Z; Jia L; Wang Y; Wang C; Wen X; Chen J; Zhu Y; Yu D; Zhou L; Chen N; Zhang S; Celik I; Ay F; Gao S; Zhang S; Li W; Hoffman AR; Cui J; Hu JF
Sci Data; 2018 Nov; 5():180255. PubMed ID: 30457566
[TBL] [Abstract][Full Text] [Related]
25. Generation of pig induced pluripotent stem cells using an extended pluripotent stem cell culture system.
Xu J; Yu L; Guo J; Xiang J; Zheng Z; Gao D; Shi B; Hao H; Jiao D; Zhong L; Wang Y; Wu J; Wei H; Han J
Stem Cell Res Ther; 2019 Jun; 10(1):193. PubMed ID: 31248457
[TBL] [Abstract][Full Text] [Related]
26. The commonality of plasticity underlying multipotent tumor cells and embryonic stem cells.
Postovit LM; Costa FF; Bischof JM; Seftor EA; Wen B; Seftor RE; Feinberg AP; Soares MB; Hendrix MJ
J Cell Biochem; 2007 Jul; 101(4):908-17. PubMed ID: 17177292
[TBL] [Abstract][Full Text] [Related]
27. Stem cells: The promises and perils of p53.
Krizhanovsky V; Lowe SW
Nature; 2009 Aug; 460(7259):1085-6. PubMed ID: 19713919
[TBL] [Abstract][Full Text] [Related]
28. Concise Review: Molecular Cytogenetics and Quality Control: Clinical Guardians for Pluripotent Stem Cells.
Rohani L; Johnson AA; Naghsh P; Rancourt DE; Ulrich H; Holland H
Stem Cells Transl Med; 2018 Dec; 7(12):867-875. PubMed ID: 30218497
[TBL] [Abstract][Full Text] [Related]
29. The emerging functions of the p53-miRNA network in stem cell biology.
Lin CP; Choi YJ; Hicks GG; He L
Cell Cycle; 2012 Jun; 11(11):2063-72. PubMed ID: 22580472
[TBL] [Abstract][Full Text] [Related]
30. Heme oxygenase-1 affects generation and spontaneous cardiac differentiation of induced pluripotent stem cells.
Stepniewski J; Pacholczak T; Skrzypczyk A; Ciesla M; Szade A; Szade K; Bidanel R; Langrzyk A; Grochowski R; Vandermeeren F; Kachamakova-Trojanowska N; Jez M; Drabik G; Nakanishi M; Jozkowicz A; Dulak J
IUBMB Life; 2018 Feb; 70(2):129-142. PubMed ID: 29316264
[TBL] [Abstract][Full Text] [Related]
31. p53 isoform Δ133p53 promotes efficiency of induced pluripotent stem cells and ensures genomic integrity during reprogramming.
Gong L; Pan X; Chen H; Rao L; Zeng Y; Hang H; Peng J; Xiao L; Chen J
Sci Rep; 2016 Nov; 6():37281. PubMed ID: 27874035
[TBL] [Abstract][Full Text] [Related]
32. bHLH Transcription Factor Math6 Antagonizes TGF-β Signalling in Reprogramming, Pluripotency and Early Cell Fate Decisions.
Divvela SSK; Nell P; Napirei M; Zaehres H; Chen J; Gerding WM; Nguyen HP; Gao S; Brand-Saberi B
Cells; 2019 Jun; 8(6):. PubMed ID: 31159500
[TBL] [Abstract][Full Text] [Related]
33. Nac1 facilitates pluripotency gene activation for establishing somatic cell reprogramming.
Choi H; Park HJ; Kim H; Kim J; Lee YK; Kim J
Biochem Biophys Res Commun; 2019 Oct; 518(2):253-258. PubMed ID: 31412978
[TBL] [Abstract][Full Text] [Related]
34. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.
Brix J; Zhou Y; Luo Y
J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984
[TBL] [Abstract][Full Text] [Related]
35. iPSCs from cancer cells: challenges and opportunities.
Ramos-Mejia V; Fraga MF; Menendez P
Trends Mol Med; 2012 May; 18(5):245-7. PubMed ID: 22521522
[TBL] [Abstract][Full Text] [Related]
36. TGF-β Signaling in Stem Cell Regulation.
Li W; Wei W; Ding S
Methods Mol Biol; 2016; 1344():137-45. PubMed ID: 26520122
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
[TBL] [Abstract][Full Text] [Related]
38. mTOR-regulated senescence and autophagy during reprogramming of somatic cells to pluripotency: a roadmap from energy metabolism to stem cell renewal and aging.
Menendez JA; Vellon L; Oliveras-Ferraros C; Cufí S; Vazquez-Martin A
Cell Cycle; 2011 Nov; 10(21):3658-77. PubMed ID: 22052357
[TBL] [Abstract][Full Text] [Related]
39. Spermatogonial stem cells and progenitors are refractory to reprogramming to pluripotency by the transcription factors Oct3/4, c-Myc, Sox2 and Klf4.
Corbineau S; Lassalle B; Givelet M; Souissi-Sarahoui I; Firlej V; Romeo PH; Allemand I; Riou L; Fouchet P
Oncotarget; 2017 Feb; 8(6):10050-10063. PubMed ID: 28052023
[TBL] [Abstract][Full Text] [Related]
40. Evolution of induced pluripotent stem cell technology.
Zhou H; Ding S
Curr Opin Hematol; 2010 Jul; 17(4):276-80. PubMed ID: 20442654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
